Suneva Medical Announces Expansion Of Its ReGenica Distribution Partnership With Obagi Medical Products

November 1, 2013

Suneva Medical, Inc., recently announced plans to expand its existing partnership with Obagi Medical Products, Inc. Suneva Medical distributes, and is the exclusive licensee for, the full line of ReGenica skincare products, and Obagi currently co-distributes ReGenica Facial Rejuvenation Complex. Under the terms of the existing agreement between the two companies, Obagi will now co-distribute ReGenica Advanced Rejuvenation Day Repair and ReGenica Advanced Rejuvenation Overnight Repair.

"Obagi has done an excellent job penetrating the marketplace with the technologically advanced ReGenica growth factor product. We look forward to working together with Obagi to expand this innovative skincare line," stated Nicholas Teti, Chairman and Chief Executive Officer of Suneva Medical, in a press release.

ReGenica was developed by Histogen, Inc.'s Chief Executive Officer and Chairman, Dr. Gail K. Naughton, a leading scientist in the field of regenerative medicine. The ReGenica product line contains Multipotent Cell Conditioned Media (CCM) Complex, which has a variety of stem cell proteins and growth factors that are characteristic of young, rapidly developing tissue and are associated with skin rejuvenation and repair. The ReGenica product line is exclusively physician-dispensed, available for purchase in dermatology, plastic surgery and other physician practices.

To learn more about ReGenica, visit

Facebook Comments


We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free